Therigy

UF’s Gator100 adds Therigy, LLC to its inaugural list of elite businesses that have proven entrepreneurial success.

Therigy, LLC is committed to rapidly getting the latest treatment information into the hands of providers for HCV and other disease states.

Therigy announces a partnership with the UHC Specialty Pharmacy Program™ selecting TherigySTM™ as the preferred application for program participants’ use in the clinical management of patients on specialty therapies.

Today Therigy announced that Jon Hamrick, Executive Vice President, Biotech & Specialty Services, will be speaking at CBI’s 10th Life Sciences Trade & Channel Strategies conference on Wednesday, December 10, 2014, at 1:30 p.m.

Therigy is pleased to announce the release of a new module, Respiratory Syncytial Virus (RSV), within its specialty therapy management application TherigySTM.

Therigy, LLC, is pleased to announce the launch of its newly designed website: http://www.therigy.com.

From more than 600 nominees, Therigy receives the distinction of being named one of the 50 Florida Companies to Watch of 2013.

Fundraiser for Cancer Care Seeks to Double Growth to Increase Benefits for...

Inaugural event receives hit marks from industry leaders for content, format, speakers and more.

The 1st Annual Specialty Pharmacy Leadership Congress will take place October 25-26, 2012, followed by the Brighten the Day 5k Run/Walk October 27, 2012